In breast cancer (BRCA), overexpression of six dark kinases is associated with decreased overall survival (ALPK3, CSNK1A1L, CSNK2A3, NRK, POMK, and PSKH1) (Tables S2 and S3). This evidence concerns the gene ALPK3 and breast cancer.